| Serial Number | 98487663 |
| Word Mark | DECIPARTICLES |
| Filing Date | Sunday, April 7, 2024 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Wednesday, August 20, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations, namely, drug preparations comprising small particles for enhanced absorption and therapeutic effect for the treatment of cancer, including pancreatic cancer, melanoma, skin cancer, lung cancer, breast cancer, prostate cancer, colorectal cancer, kidney cancer, stomach cancer, ovarian cancer, cervical cancer, liver cancer, multiple myeloma, lymphoma, glioma, glioblastoma, diffuse midline glioma, brain or spinal cancer, CNS tumors, HIV-AIDS, myelodysplastic disease, leukemia, hypertension, epilepsy, seizures, schizophrenia, bipolar disorder, psychosis, depressive disorder, dementia, obsessive-compulsive disorder, Huntington's disease, Parkinson's disease, fungal infection, hyperlipidemia, hyperlipoproteinemia, hypertriglyceridemia, hyperglycemia, diabetes, inflammatory disease, obesity, fever, pain, asthma, bronchospasm, bacterial infection, pneumonia, pulmonary hypertension, and malaria; Drug delivery agents in the form of pharaceutical preparations comprising small particles that facilitate the delivery of pharmaceutical preparations for the treatment of cancer, including pancreatic cancer, melanoma, skin cancer, lung cancer, breast cancer, prostate cancer, colorectal cancer, kidney cancer, stomach cancer, ovarian cancer, cervical cancer, liver cancer, multiple myeloma, lymphoma, glioma, glioblastoma, diffuse midline glioma, brain or spinal cancer, CNS tumors, HIV-AIDS, myelodysplastic disease, leukemia, hypertension, epilepsy, seizures, schizophrenia, bipolar disorder, psychosis, depressive disorder, dementia, obsessive-compulsive disorder, Huntington's disease, Parkinson's disease, fungal infection, hyperlipidemia, hyperlipoproteinemia, hypertriglyceridemia, hyperglycemia, diabetes, inflammatory disease, obesity, fever, pain, asthma, bronchospasm, bacterial infection, pneumonia, pulmonary hypertension, and malaria |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, April 7, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Sapu Bioscience, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Wanchai 12345 HK |
| Event Date | Event Description |
| Sunday, April 7, 2024 | NEW APPLICATION ENTERED |
| Saturday, December 14, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, December 15, 2024 | ASSIGNED TO EXAMINER |
| Thursday, December 19, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, December 19, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, December 19, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 11, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, March 11, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, June 18, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 18, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 18, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 20, 2025 | FINAL REFUSAL WRITTEN |
| Wednesday, August 20, 2025 | FINAL REFUSAL E-MAILED |
| Wednesday, August 20, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Sunday, November 16, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Sunday, November 16, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Tuesday, February 10, 2026 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Tuesday, February 10, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 10, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |